Expensify Announces Q1 2022 Results
Free Plan membership grew 183% Q/Q to over 9,000 customers. The company generated positive cash flow of
“The biggest news coming out of Q1 was the growth of our Free Plan for SMBs. The plan grew to over 9,000 customers, which is an 183% increase from last quarter. The plan allows members to roll out
“In addition to the incredible growth we’re seeing from the Free Plan, March '22 was the second best month in company history from a paid member perspective,” says
First Quarter 2022 Highlights
Financial:
-
Revenue was
$40.4 million , an increase of 36% from the same period last year. -
Positive operating cash flows of
$11.2 million . -
Net (loss) income was
$(7.4) million , compared to$8.0 million for the same period last year. This loss is driven by stock-based compensation expenses of$14.7 million . -
Non-GAAP net income was
$7.3 million . -
Adjusted EBITDA was
$11.0 million , with an Adjusted EBITDA margin of 27%.
Business
- Free plan - swelled to over 9,000 businesses in Q1, a 183% increase from the previous quarter. The Free Plan includes the Expensify Card, expense management, next-day reimbursement, invoicing, bill pay, and travel booking.
- Paid members - despite the challenges presented by the COVID-19 Omicron spike early in the year, a strong second half of Q1 propelled average paid members for the quarter to 706,000, exceeding expectations.
- Expensify Card - continues to perform well, interchange increased by 150% from the same period last year.
- CPA Card - announced in January as the first smart card with exclusive perks, pricing, and upgrades for CPAs, accounting firms, and their clients.
Financial Outlook
We reaffirm our long term guidance provided in connection with our fourth quarter 2021 results of 25-35% revenue growth over a multi-year period.
Est. stock-based compensation (millions) |
||||||||||||||||||
|
||||||||||||||||||
|
Q2 2022 |
Q3 2022 |
Q4 2022 |
|||||||||||||||
|
Low |
High |
Low |
High |
Low |
High |
||||||||||||
Cost of revenue, net |
$ |
4.8 |
$ |
5.4 |
$ |
4.6 |
$ |
5.3 |
$ |
3.4 |
$ |
4.1 |
||||||
Research and development |
|
2.7 |
|
3.0 |
|
2.6 |
|
2.9 |
|
1.9 |
|
2.3 |
||||||
General and administrative |
|
4.6 |
|
5.3 |
|
4.5 |
|
5.1 |
|
3.3 |
|
4.0 |
||||||
Sales and marketing |
|
2.0 |
|
2.2 |
|
1.9 |
|
2.2 |
|
1.4 |
|
1.7 |
||||||
Total |
$ |
14.0 |
$ |
16.0 |
$ |
13.5 |
$ |
15.5 |
$ |
10.0 |
$ |
12.0 |
||||||
|
||||||||||||||||||
Note: Amounts may not sum due to minor rounding differences. |
Availability of Information on Expensify’s Website
Investors and others should note that
Conference Call
Non-GAAP Financial Measures
In addition to financial measures prepared in accordance with
We believe our non-GAAP financial measures are useful in evaluating our business, measuring our performance, identifying trends affecting our business, formulating business plans and making strategic decisions. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our results of operations in the same manner as our management team. These non-GAAP financial measures are presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from similarly titled metrics or measures presented by other companies. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. All of these limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business. A reconciliation of each non-GAAP financial measure to the most directly comparable financial measure stated in accordance with GAAP is at the end of this press release.
We define Adjusted EBITDA as net income from operations excluding provision for income taxes, interest and other expenses, net, depreciation and amortization and stock based compensation.
We define non-GAAP net income as net income from operations in accordance with US GAAP excluding stock-based compensation and IPO-related bonus costs. In prior periods, this metric only excluded IPO-related bonus costs and did not exclude expenses related to stock-based compensation. However, management now believes that further excluding stock-based compensation from non-GAAP net income is useful to better understand the financial performance of our business and to facilitate a better comparison of our results to those of peer companies over multiple periods given that this item may vary between companies for reasons unrelated to overall operating performance. IPO-related bonus costs impacted the second, third and fourth fiscal quarters of 2021, but are not expected to impact future periods beginning with the first quarter of 2022.
The tables at the end of the Financial Statements provide reconciliations to the most directly comparable GAAP financial measure to each of these non-GAAP financial measures.
Forward-Looking Statements
Forward-looking statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1955. These statements include statements regarding our strategy, future financial condition, future operations, projected costs, prospects, plans, objectives of management and expected market growth and involve known and unknown risks that are difficult to predict. As a result, our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “shall,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “goal,” “objective,” “seeks,” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: the economic, political and social impact of, and uncertainty relating to, the COVID-19 pandemic; the war in
About
Condensed Consolidated Balance Sheets (unaudited, in thousands, except share and per share data) |
||||||||
|
As of |
As of |
||||||
|
2022 |
2021 |
||||||
Assets |
|
|
||||||
Cash and cash equivalents |
$ |
101,101 |
|
$ |
98,398 |
|
||
Accounts receivable, net |
|
16,022 |
|
|
15,713 |
|
||
Settlement assets |
|
34,313 |
|
|
21,880 |
|
||
Prepaid expenses |
|
7,060 |
|
|
7,436 |
|
||
Related party loan receivable, current |
|
— |
|
|
14 |
|
||
Other current assets |
|
15,746 |
|
|
14,201 |
|
||
Total current assets |
|
174,242 |
|
|
157,642 |
|
||
Capitalized software, net |
|
6,158 |
|
|
6,359 |
|
||
Property and equipment, net |
|
15,584 |
|
|
15,930 |
|
||
Lease right-of-use assets |
|
1,832 |
|
|
2,202 |
|
||
Deferred tax assets, net |
|
370 |
|
|
370 |
|
||
Other assets |
|
628 |
|
|
710 |
|
||
Total assets |
$ |
198,814 |
|
$ |
183,213 |
|
||
Liabilities and stockholders' equity |
|
|
||||||
Accounts payable |
$ |
1,437 |
|
$ |
3,752 |
|
||
Accrued expenses and other liabilities |
|
8,411 |
|
|
11,046 |
|
||
Borrowings under line of credit |
|
15,000 |
|
|
15,000 |
|
||
Current portion of long-term debt, net of issuance costs |
|
547 |
|
|
549 |
|
||
Lease liabilities, current |
|
1,559 |
|
|
1,549 |
|
||
Settlement liabilities |
|
34,113 |
|
|
21,680 |
|
||
Total current liabilities |
|
61,067 |
|
|
53,576 |
|
||
Lease liabilities, non-current |
|
405 |
|
|
802 |
|
||
Other liabilities |
|
1,028 |
|
|
153 |
|
||
Long-term debt, net of issuance costs |
|
51,847 |
|
|
52,067 |
|
||
Total liabilities |
|
114,347 |
|
|
106,598 |
|
||
Commitments and contingencies (Note 4) |
|
|
||||||
Stockholders' equity: |
|
|
||||||
Common stock, par value |
|
6 |
|
|
6 |
|
||
Additional paid-in capital |
|
157,743 |
|
|
142,515 |
|
||
Accumulated deficit |
|
(73,282 |
) |
|
(65,906 |
) |
||
Total stockholders' equity |
|
84,467 |
|
|
76,615 |
|
||
Total liabilities and stockholders' equity |
$ |
198,814 |
|
$ |
183,213 |
|
||
|
|
|
Condensed Consolidated Statements of Income (unaudited, in thousands, except share and per share data) |
||||||||
Three months ended |
||||||||
|
2022 |
2021 |
||||||
Revenue |
$ |
40,370 |
|
$ |
29,720 |
|
||
Cost of revenue, net(1) |
|
14,133 |
|
|
7,637 |
|
||
Gross margin |
|
26,237 |
|
|
22,083 |
|
||
Operating expenses: |
|
|
||||||
Research and development(1) |
|
3,701 |
|
|
1,097 |
|
||
General and administrative(1) |
|
14,006 |
|
|
6,367 |
|
||
Sales and marketing(1) |
|
13,372 |
|
|
3,077 |
|
||
Total operating expenses |
|
31,079 |
|
|
10,541 |
|
||
(Loss) income from operations |
|
(4,842 |
) |
|
11,542 |
|
||
Interest and other expenses, net |
|
(902 |
) |
|
(737 |
) |
||
(Loss) income before income taxes |
|
(5,744 |
) |
|
10,805 |
|
||
Provision for income taxes |
|
(1,632 |
) |
|
(2,762 |
) |
||
Net (loss) income |
$ |
(7,376 |
) |
$ |
8,043 |
|
||
|
|
|
||||||
Less: income allocated to participating securities |
|
— |
|
|
(5,547 |
) |
||
Net (loss) income attributable to Class A, LT10 and LT50 common stockholders |
$ |
(7,376 |
) |
$ |
2,496 |
|
||
Net (loss) income per share attributable to Class A, LT10 and LT50 common stockholders: |
|
|
||||||
Basic |
$ |
(0.09 |
) |
$ |
0.08 |
|
||
Diluted |
$ |
(0.09 |
) |
$ |
0.06 |
|
||
Weighted-average shares of common stock used to compute net (loss) income per share attributable to Class A, LT10 and LT50 common stockholders: |
|
|
||||||
Basic |
|
80,147,208 |
|
|
29,522,409 |
|
||
Diluted |
|
80,147,208 |
|
|
40,576,339 |
|
||
|
|
|
|
||||||
|
Three months ended |
|||||
|
2022 |
2021 |
||||
|
(in thousands) |
|||||
Cost of revenue, net |
$ |
4,908 |
$ |
188 |
||
Research and development |
|
2,708 |
|
154 |
||
General and administrative |
|
4,975 |
|
304 |
||
Sales and marketing |
|
2,076 |
|
64 |
||
Total stock-based compensation expense |
$ |
14,667 |
$ |
710 |
||
|
|
|
Condensed Consolidated Statements of Cash Flows (unaudited, in thousands) |
||||||||
|
Three months ended |
|||||||
|
2022 |
2021 |
||||||
Cash flows from operating activities: |
|
|
||||||
Net (loss) income |
$ |
(7,376 |
) |
$ |
8,043 |
|
||
Adjustments to reconcile net (loss) income to net cash provided (used) by operating activities: |
|
|
||||||
Depreciation and amortization |
|
1,167 |
|
|
1,170 |
|
||
Reduction of operating lease right-of-use assets |
|
185 |
|
|
181 |
|
||
Loss on impairment, receivables and sale or disposal of equipment |
|
231 |
|
|
56 |
|
||
Stock-based compensation |
|
14,667 |
|
|
710 |
|
||
Amortization of debt issuance costs |
|
10 |
|
|
8 |
|
||
Changes in assets and liabilities: |
|
|
||||||
Accounts receivable |
|
(482 |
) |
|
(1,601 |
) |
||
Related party loan receivables |
|
14 |
|
|
— |
|
||
Settlement assets |
|
(5,689 |
) |
|
464 |
|
||
Prepaid expenses |
|
377 |
|
|
(1,642 |
) |
||
Other current assets |
|
(224 |
) |
|
318 |
|
||
Other assets |
|
80 |
|
|
9 |
|
||
Accounts payable |
|
(2,316 |
) |
|
236 |
|
||
Accrued expenses and other liabilities |
|
(2,635 |
) |
|
2,821 |
|
||
Operating lease liabilities |
|
(6 |
) |
|
(200 |
) |
||
Settlement liabilities |
|
12,433 |
|
|
(980 |
) |
||
Other liabilities |
|
787 |
|
|
316 |
|
||
Net cash provided by operating activities |
|
11,223 |
|
|
9,909 |
|
||
Cash flows from investing activities: |
|
|
||||||
Purchase of property and equipment |
|
(179 |
) |
|
(284 |
) |
||
Software development costs |
|
(494 |
) |
|
(669 |
) |
||
Net cash used by investing activities |
|
(673 |
) |
|
(953 |
) |
||
Cash flows from financing activities: |
|
|
||||||
Principal payments of finance leases |
|
(197 |
) |
|
(192 |
) |
||
Principal payments of term loan |
|
(146 |
) |
|
(616 |
) |
||
Payments of deferred offering costs |
|
— |
|
|
(400 |
) |
||
Vesting of restricted common stock |
|
295 |
|
|
— |
|
||
Issuance of restricted stock units |
|
18 |
|
|
— |
|
||
Repurchases of early exercised stock options |
|
(4 |
) |
|
— |
|
||
Proceeds from issuance of common stock on exercise of stock options |
|
252 |
|
|
125 |
|
||
Net cash provided by financing activities |
|
218 |
|
|
(1,083 |
) |
||
Net increase in cash and cash equivalents |
|
10,768 |
|
|
7,873 |
|
||
Cash and cash equivalents and restricted cash, beginning of period |
|
125,315 |
|
|
46,878 |
|
||
Cash and cash equivalents and restricted cash, end of period |
$ |
136,083 |
|
$ |
54,751 |
|
||
Supplemental disclosure of cash flow information: |
|
|
||||||
Cash paid for interest |
$ |
267 |
|
$ |
723 |
|
||
Cash paid for income taxes |
$ |
284 |
|
$ |
263 |
|
||
Noncash investing and financing items: |
|
|
||||||
Accrued deferred offering costs |
$ |
— |
|
$ |
531 |
|
||
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets |
|
|
||||||
Cash and cash equivalents |
$ |
101,101 |
|
$ |
41,926 |
|
||
Restricted cash included in other current assets |
|
9,973 |
|
|
2,818 |
|
||
Restricted cash included in other assets |
|
46 |
|
|
48 |
|
||
Restricted cash included in settlement assets |
|
24,963 |
|
|
9,959 |
|
||
Total cash, cash equivalents and restricted cash |
$ |
136,083 |
|
$ |
54,751 |
|
||
|
|
|
Reconciliation of GAAP to Non-GAAP Financial Measures (unaudited, in thousands) |
|||
Adjusted EBITDA |
|||
|
Three months ended |
||
|
2022 |
||
|
(in thousands, except percentages) |
||
Net (loss) income |
$ |
(7,376) |
|
Net (loss) income margin |
|
(18) % |
|
Add: |
|
||
Provision for income taxes |
|
1,632 |
|
Interest and other expenses, net |
|
902 |
|
Depreciation and amortization |
|
1,167 |
|
Stock-based compensation |
|
14,667 |
|
Adjusted EBITDA |
$ |
10,992 |
|
Adjusted EBITDA margin |
|
27 % |
|
|
|
Non-GAAP net income |
|||
|
Three months ended |
||
|
2022 |
||
|
(in thousands, except percentages) |
||
Net (loss) income |
$ |
(7,376) |
|
Net (loss) income margin |
|
(18) % |
|
Add: |
|
||
Stock-based compensation |
|
14,667 |
|
IPO-related bonus expense |
|
— |
|
Non-GAAP net income |
$ |
7,291 |
|
Non-GAAP net income margin |
|
18 % |
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220512005387/en/
Investor Relations Contact
investors@expensify.com
Press Contact
press@expensify.com
Source: